Synlab has opened its first retail blood collection point (BCP) dedicated solely to wellness and genetic testing, which it claims is the first in Europe.
Spain's large and liberal IVF market has long attracted a steady stream of medical tourists into the country, but as other Europe markets catch up, this is beginning to dwindle. With the market already consolidated, where does this leave growth in the country's sector? HBI talks to an operator to find out more.
DomusVi, Spain's largest nursing home operator by revenue, is entering a partnership with Axa Partners and Philips to extend its medicalised homecare offering. The trio will deliver medical technology to clients suffering from respiratory diseases such as chronic obstructive pulmonary disease (COPD) and breathing difficulties due to asthma. A pilot is underway involving 60 people […]
LSE-listed Integrated Diagnostics Holdings (IDH) has released its full-year results showing substantial growth in profits, revenue and EBITDA. The lab group, which was brought to IPO by CEO Hend el Sherbini in 2015 and is present in Egypt, Jordan, Sudan and Nigeria, has added an additional 40 branches to its network in the last year, […]
We talk to the new CEO of CEE group Penta Hospitals International (PHI). Martin Hrezo discusses current markets Poland, Slovakia and Czechia, the synergies between them and why it decided to slow down its international expansion.
Spanish medicalised homecare specialist Qida has developed a business model that it claims could bump margins in a traditionally low margin market. We speak to the company's founder and CEO about its model and how it plans to tackle the biggest challenges in for-profit homecare.
Brazilian diagnostics company DASA has reported losses of R $14.5m ($3.8m) for the last quarter of 2018. We ask the company why, and talk to a market expert about its strategy.
Four Seasons, the UK's third largest care home group by revenue, has secured further funding from its creditor, US hedge fund H/2 Capital, to tide it over until a sale. We speak to a market adviser about the issues investors will be encountering when looking at this asset. It has been officially up for sale since November last year.
We talk to Dr Lajos Fabian, chairman of MedAlliance Holding, a grouping of seven investors which has been busy buying healthcare providers in the fragmented Hungarian healthcare market through its buy-and-build platform Tritonlife, which it launched in late 2018. The aim is to replicate the achievements of Medigroup in Serbia and Regina Maria in Romania with eventual sale or IPO, but not for at least 5-7 years.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
